addition of cabazitaxel to abiraterone/prednisone significantly prolonged pfs in extensive disea...
Published 2 months ago • 13 plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
1:17
dr kyriakopoulos on adding cabazitaxel to abiraterone/prednisone in patients with mcrpc
-
7:12
abiraterone acetate/prednisone apalutimide and adt post-op srt may improve pfs and mfs
-
2:07
chaarted2: cabazitaxel plus abiraterone vs. abiraterone alone for metastatic crpc
-
6:48
adding abiraterone acetate plus prednisolone to standard therapy lengthens survival in non-metas...
-
4:06
combination of abiraterone and cabazitaxel in metastatic castration-resistant prostate cancer
-
6:50
peace-1: abiraterone acetate plus prednisone and/or local radiotherapy in men with de novo mcspc
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
7:09
overall survival with abiraterone acetate plus prednisone in peace-1
-
2:04
a phase ii trial investigating neoadjuvant abiraterone and cabazitaxel in high-risk prostate cancer
-
1:14
dr. dreicer on abiraterone and enzalutamide in prostate cancer
-
4:38
stampede: abiraterone acetate plus prednisolone or docetaxel
-
5:59
apalutamide in combination with abiraterone acetate, docetaxel and prednisone for mcrpc
-
1:22
cabazitaxel improves rpfs in patients with mcrpc
-
1:05
dr. agarwal on candidates for docetaxel versus abiraterone and prednisone
-
2:13
head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic crpc
-
0:33
expert discusses toxicity results in card study
-
0:34
discussing the safety profile of cabazitaxel in mcrpc
-
2:31
abiraterone: a step forward in the treatment of prostate cancer